ImmuCell Corporation ( ICCC) - Key Metrics

ICCC Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $0.79 $0.20 $0.33 $0.25
2026Q1 $1.14 $0.21 $0.39 $0.38
2025Q4 $0.84 -$0.31 $0.05 $0.03
2025Q3 $0.61 -$0.02 -$0.13 -$0.20
2025Q2 $0.71 $0.06 $0.18 $0.16

ICCC Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 12.56
2026Q1 0% 7.54
2025Q4 0% -4.96
2025Q3 0% -101.46
2025Q2 0% 31.29

ICCC Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 2.51% 0%
2026Q1 5.93% 0%
2025Q4 0.56% 0%
2025Q3 -3.14% 0%
2025Q2 2.30% 0%

ICCC

Price: $9.76

52 week price:
4.52
12.10

Earnings Per Share: 0.07 USD

P/E Ratio: 143.57

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 8519

Ebitda: 1.2 million

Market Capitalization: 91.3 million

Links: